S. 139 — A bill to permanently allow an exclusion under the Supplemental Security Income Program and the Medicaid Program for compensation provided to individuals who participate in clinical trials for rare diseases or conditions; to the Committee on Finance.

By Mr. WYDEN (for himself, Mr. Hatch, Mr. Markey, and Mr. Brown), S100 [8JA]

Text, S105 [8JA], S5175 [16JY]

Cosponsors added, S201 [13JA], S984 [12FE], S1118 [25FE], S1384 [10MR], S1528 [16MR], S1629 [18MR], S2110 [13AP], S2473 [28AP], S3406 [1JN], S4649 [25JN], S4953 [9JY]

Committee discharged. Passed Senate, S5175 [16JY]

Message from the Senate, H5295 [20JY]

Referred to the Committees on Ways and Means; Energy and Commerce, H5295 [20JY]

Rules suspended. Passed House, H6276 [28SE]

Text, H6276 [28SE]

Message from the House, S7004 [29SE], S7046 [30SE]

Examined and signed in the Senate, S7046 [30SE]

Examined and signed in the House, H6747 [30SE]

Presented to the President (September 30, 2015), S7099 [1OC]

Approved [Public Law 114–63] (signed October 7, 2015)